The role of comorbidity and frailty in shaping the burden of atrial fibrillation: a multinational cross-sectional survey
Adele Ravelli, Caterina Trevisan, José Miguel Rivera‐Caravaca, Bruno Micael Zanforlini et autres
1 citationScientific Reports
Advicenne Pharma (France)
Nîmes · FR · company
44Publications signalées
921Citations signalées
12Thèmes principaux
Principaux domaines
Ion Transport and Channel RegulationRenal function and acid-base balanceAnesthesia and Sedative AgentsKidney Stones and Urolithiasis TreatmentsElectrolyte and hormonal disordersPotassium and Related DisordersBiomedical Research and PathophysiologyGastroesophageal reflux and treatmentsPediatric Urology and Nephrology StudiesPharmaceutical studies and practicesAnesthesia and Neurotoxicity ResearchAtrial Fibrillation Management and Outcomes
Évolution annuelle
Publications récentes
Use of Software as a Medical Device to Improve Therapeutic Adherence in Patients With Hematological Malignancies: Prospective Interventional MargheRITA Study
Serena Dalto, Antonella Romanelli, Martina Violati, Carlotta Galeone et autres
0 citationsJMIR mhealth and uhealth
Evaluating the Safety and Performance of the KidneYou App for Chronic Kidney Disease: Protocol for an Italian Multicenter, Randomized, Open-Label, Premarket Study
Cesira Cafiero, Marco Gnesi, Anna Rita Maurizi, Giorgia Campilongo et autres
0 citationsJMIR Research Protocols
6-year treatment follow-up with an extended-release alkaline formulation (Sibnayal®) in primary distal renal tubular acidosis
Aurélia Bertholet‐Thomas, Aurélie De Mul, Julie Bernardor, Gwenaëlle Roussey‐Kesler et autres
0 citationsOrphanet Journal of Rare Diseases
Frailty increases the risk of hospitalization for atrial fibrillation in older adults: a population-based cohort study
Caterina Trevisan, Chiara Ceolin, Davide Liborio Vetrano, Mirko Petrović et autres
4 citationsNutrition Metabolism and Cardiovascular Diseases
Long-term clinical outcomes with an average of 6 years follow-up in dRTA patients treated with ADV7103 an oral twice-daily fixed and prolonged-release combination of potassium bicarbonate and potassium citrate (Sibnayal®).
Aurélia Bertholet‐Thomas, Aurélie De-Mul, Gwenaëlle Roussey‐Kesler, Ľudmila Podracká et autres
0 citationsResearch Square
Clinical Data Standards and Data Anonymization Considerations for Academic Organizations: International Cross-Sectional Survey
0 citationsJournal of the Society for Clinical Data Management
#2746 Long-term benefits in dRTA patients treated with Sibnayal®, a prolonged-release combination of potassium bicarbonate and citrate: 6-year results
Aurélia Bertholet‐Thomas, Julie Bernardor, Aurélie De Mul, Gwenaëlle Roussey‐Kesler et autres
0 citationsNephrology Dialysis Transplantation
Use of Software as a Medical Device to Improve Therapeutic Adherence in Patients With Hematological Malignancies: Prospective Interventional MargheRITA Study (Preprint)
0 citations
An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup
Léonore Diezi, Kim Dao, Vincent Jullien, Caroline Roussel‐Maupetit et autres
4 citationsPharmacology Research & Perspectives
Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103)
Aurélia Bertholet‐Thomas, Maria A. Manso-Silván, Victor Navas-Serrano, Catherine Guittet et autres
5 citationsNefrología (English Edition)
Improved growth of a child with primary distal renal tubular acidosis after switching from a conventional alkalizing treatment to a new prolonged-release formulation containing potassium citrate and potassium bicarbonate: lessons for the clinical nephrologist
Olivia Boyer, Maria A. Manso-Silván, Sophie Joukoff, Romain Berthaud et autres
4 citationsJournal of Nephrology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.